CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer

Miso Kim, Bhumsuk Keam, Tae-Min Kim, Hoon-Gu Kim, Jin-Soo Kim, Sung Sook Lee, Seong Hoon Shin, Min Kyoung Kim, Keon Uk Park, Dong-Wan Kim, Hwan Jung Yun, Jong Seok Lee, Dae Seog Heo

Cancer Research and Treatment. 2017;49(2):416-422. Published online 2016 July 28 DOI: https://doi.org/10.4143/crt.2016.121

Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer

Miso Kim, Bhumsuk Keam, Tae-Min Kim, Hoon-Gu Kim, Jin-Soo Kim, Sung Sook Lee, Seong Hoon Shin, Min Kyoung Kim, Keon Uk Park, Dong-Wan Kim, Hwan Jung Yun, Jong Seok Lee, Dae Seog Heo

Cancer Research and Treatment. 2017;49(2):416-422

Link1 Link2

Link3

A phase I trial of combination chemotherapy with irinotecan(CPT-II). Cisplatin and vindesine in advanced non-small cell lung cancer (NSCLC)

Lung Cancer. 1994;11:126

Link1 Link2

Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma

Ajay Anand, Abhay Anand, Namrata Anand

Cancer. 1996;77(9):1959-1960

Link1 Link2

P-207 Docetaxel and irinotecan as first line chemotherapy in patients with unresectable locally advanced or metastatic non small cell lung cancer (NSCLC): A phase II study

Gesine Groth, Martin Reck, Hansjochen Wilke, Thomas Büchele, Klaus Schäfer, Ulrich Gatzemeier

Lung Cancer. 2003;41:S143-S144

Link1 Link2

Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer

Imjai Chitapanarux, Anun Tonusin, Vimol Sukthomya, Chamita Charuchinda, Nantaka Pukanhapan, Vicharn Lorvidhaya

Gynecologic Oncology. 2003;89(3):402-407

Link1 Link2

Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis

Changhoon Yoo, Min-Hee Ryu, Young-Soon Na, Baek-Yeol Ryoo, Chae-Won Lee, Yoon-Koo Kang

British Journal of Cancer. 2016;114(11):1185-1190

Link1

Link2 Link3

Phase II study of chemotherapy with VP16, ifosfamide and cisplatin (VIP) in the treatment of unresectable advanced non small cell lung cancer

Lung Cancer. 1994;11:128

Link1 Link2

Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer

Shinya Ueda, Shuichi Hironaka, Narikazu Boku, Akira Fukutomi, Takayuki Yoshino, Yusuke Onozawa

Gastric Cancer. 2006;9(3):203-207

Link1

Link2 Link3

Phase II Study of Irinotecan, High-dose 5-fluorouracil, and Leucovorin Combination Chemotherapy in Taxane and Cisplatin-based Chemotherapy-refractory Metastatic Gastric Cancer

Ju-Young Yoon, Sung-Ji Lee, Dae-Ho Cho, Sung-Yoon Rew, Dae-Eun Kim, Jun-Eul Hwang, Woo-Kyun Bae, Hyun-Jeong Shim, Sang-Hee Cho, Ik-Joo Chung

Chonnam Medical Journal. 2009;45(2):79

Link1 Link2 Link3

Unresectable non metastatic squamous cell carcinoma of the lung: Phase II study of radical radiotherapy and combined chemotherapy

Lung Cancer. 1985;1(3-4):82

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.